Outcomes and prognostic factors in patients with synchronous endometrial and ovarian cancer
Archives of Gynecology and Obstetrics · 04.09.2025 · 312 (5) · 1727-1735
DOI: 10.1007/s00404-025-08164-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 04.09.2025. Verfasst von Xiaofei Lu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, 100044, China. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Ovarian Neoplasms, Neoplasms, Multiple Primary, Carcinoma, Endometrioid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality,China, Natural Science Foundation of Beijing Municipality,China北京市自然科学基金.
Abstract (Originalsprache)
PURPOSE: To analyze prognostic factors and survival outcomes in patients with synchronous endometrial and ovarian cancer (SEOC) to guide clinical management. METHODS: We conducted a retrospective cohort study of patients diagnosed with SEOC at Peking University People's Hospital between January 2004 and December 2024. Clinicopathological data were collected, and oncological outcomes, including progression-free survival (PFS) and overall survival (OS), were analyzed along with their associated prognostic factors. RESULTS: Among 64 included patients, vaginal bleeding was the predominant presenting symptom. Thirty-six patients were diagnosed with concordant endometrioid carcinoma, which was the most common histological type. All patients underwent surgical treatment, among whom 56 received platinum-based chemotherapy postoperatively, with a platinum sensitivity rate of 67.9%. The median PFS and OS were 27 months (range 3-215) and 41 months (range 7-246), respectively. On multivariate analysis, advanced FIGO stage of ovarian cancer (HR = 2.764; 95% CI 1.169-6.536, P = 0.021) independently predicted worse PFS, while platinum resistance (HR = 6.962; 95% CI 2.052-23.619, P = 0.002) was significantly associated with reduced OS. CONCLUSIONS: In this cohort, platinum sensitivity was observed in 67.9% of cases. The advanced ovarian FIGO stage and platinum resistance independently correlated with inferior survival, underscoring the urgent need for tailored therapeutic strategies and intensified surveillance in platinum-resistant SEOC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, 100044, China.
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, 100044, China. honglanzhu01@163.com.
Förderung
- Natural Science Foundation of Beijing Municipality,China
- Natural Science Foundation of Beijing Municipality,China北京市自然科学基金
Zitieren
APA
Lu, X., & Zhu, H. (2025). Outcomes and prognostic factors in patients with synchronous endometrial and ovarian cancer. Archives of Gynecology and Obstetrics, 312(5), 1727-1735. https://doi.org/10.1007/s00404-025-08164-7
Vancouver
Lu X, Zhu H. Outcomes and prognostic factors in patients with synchronous endometrial and ovarian cancer. Archives of Gynecology and Obstetrics. 2025;312(5):1727-1735. doi:10.1007/s00404-025-08164-7
BibTeX
@article{Lu2025,
author = {Lu, Xiaofei and Zhu, Honglan},
title = {Outcomes and prognostic factors in patients with synchronous endometrial and ovarian cancer},
journal = {Archives of Gynecology and Obstetrics},
year = {2025},
volume = {312},
number = {5},
pages = {1727--1735},
doi = {10.1007/s00404-025-08164-7}
}
EUVIMED